Purdue Pharma L.P. ("Purdue") has entered into an agreement to have its pipeline medication tinostamustine included in the Phase 2/3 GBM AGILE (Glioblastoma Adaptive Global Innovative Learning ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, has won Platinum in the AI Research Innovation category at the 2025 Pinnacle Awards. This recognition underscores ...

“Pilavapadin, an oral, non-opioid, AAK1 inhibitor for diabetic peripheral neuropathic pain (DPNP): results from a Phase 2b, dose-ranging, randomized, placebo-controlled, multicenter study” was ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

ShiraTronics, Inc., a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic ...

Site networks can be a powerful engine for this kind of change. When built on collaboration, not control, and focused on capability over conformity, they allow more sites to engage in research, more ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Launch of digital twins and virtual patients to accelerate and enhance clinical trials • Integration of AI modules into Exagis, Axiodis' proprietary eCRF solution Leuven, BELGIUM, September 16, ...